This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shah, N P Articles by Denny, C T Search for Related Content PubMed PubMed Citation Articles by Shah, N P Articles by Denny, C T

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 April; 11(4): 1854-1860

Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines.

Department of Microbiology and Molecular Genetics, University of California-Los Angeles 90024.

ABSTRACT

The t(9;22) Philadelphia chromosome translocation fuses 5' regulatory and coding sequences of the BCR gene to the c-ABL proto-oncogene. This results in the formation of hybrid BCR-ABL mRNAs and proteins. The shift in ABL transcriptional control to the BCR promoter may play a role in cellular transformation mediated by this rearrangement. We have functionally localized the BCR promoter to a region 1 kb 5' of BCR exon 1 coding sequences by using a chloramphenicol acetyltransferase reporter gene assay. Nucleotide sequence analysis of this region revealed many consensus binding sequences for transcription factor SP1 as well as two potential CCAAT box binding factor sites and one putative helix-loop-helix transcription factor binding site. No TATA-like or "initiator" element sequences were found. Because of low steady-state levels of BCR mRNA and the high GC content (78%) of the promoter region, definitive mapping of transcription start sites required artificial amplification of BCR promoter-directed transcripts. Overexpression from the BCR promoter in a COS cell system was effective in demonstrating multiple transcription initiation sites. In order to assess the effects of chromosomal translocation on the transcriptional control of the BCR gene, we determined S1 nuclease protection patterns of poly(A)+ RNA from tumor cell lines. No differences were observed in the locations and levels of BCR transcription initiation sites between those lines that harbored the t(9;22) translocation and those that did not. This demonstrates that BCR promoter function remains intact in spite of genomic rearrangement. The BCR promoter is structurally similar to the ABL promoters. Together, this suggests that the structural fusion of BCR-ABL and not its transcriptional deregulation is primarily responsible for the transforming effect of the t(9;22) translocation.

This article has been cited by other articles:

• Chong, A., Zhang, G., Bajic, V. B. (2003). FIE2: a program for the extraction of genomic DNA sequences around the start and translation initiation site of human genes. Nucleic Acids Res 31: 3546-3553 [Abstract] [Full Text]  
• Laurent, E., Talpaz, M., Kantarjian, H., Kurzrock, R. (2001). The BCR Gene and Philadelphia Chromosome-positive Leukemogenesis. Cancer Res. 61: 2343-2355 [Full Text]  
• Auer, R. L., Jones, C., Mullenbach, R. A., Syndercombe-Court, D., Milligan, D. W., Fegan, C. D., Cotter, F. E. (2001). Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood 97: 509-515 [Abstract] [Full Text]  
• Mahon, F. X., Deininger, M. W. N., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J. M., Melo, J. V. (2000). Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood 96: 1070-1079 [Abstract] [Full Text]